An Initial Low-Dose Etelcalcetide Dosing Strategy in Hemodialysis Patients With Moderate Secondary Hyperparathyroidism is Effective and Cost-Saving-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An Initial Low-Dose Etelcalcetide Dosing Strategy in Hemodialysis Patients With Moderate Secondary Hyperparathyroidism is Effective and Cost-Saving

Published:2024-02 Issue:2 Volume:9 Page:482-485
ISSN:2468-0249
Container-title:Kidney International Reports
language:en
Short-container-title:Kidney International Reports

Author:

Carta Andrea,Tedesco Martina,Mescia Federica,Manenti Chiara,Lucca Bernardo,Verzeletti Federica,Guerini Alice,Terni Federica Gaia,Zubani Roberto,Guerini Simona,Valzorio Brunella,Jeannin Guido,Carli Orsola,Camerini Corrado,Possenti Stefano,Gaggia Paola,Alberici Federico

Publisher

Elsevier BV

Subject

Nephrology

Reference5 articles.

1. One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism;Bushinsky;Nephrol Dial Transplant,2020

2. Randomized trial of etelcalcetide for cardiac hypertrophy in hemodialysis;Dörr;Circ Res,2021

3. Etelcalcetide is effective at all levels of severity of secondary hyperparathyroidism in hemodialysis patients;Cunningham;Kidney Int Rep,2019

4. Etelcalcetide utilization, dosing titration, and Chronic Kidney Disease–Mineral and Bone Disease (CKD-MBD) marker responses in US hemodialysis patients;Karaboyas;Am J Kidney Dis,2022

5. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study;Tentori;Clin J Am Soc Nephrol CJASN,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP